Long-Term Outcomes in Patients With Isocitrate Dehydrogenase-Mutated Grade 2 Glioma Who Never Received Adjuvant Oncological Treatment After Upfront Mapping-Based Surgical Resection.

Abstract excerpt

BACKGROUND AND OBJECTIVES: Patients with low-grade glioma (LGG) have a long-life expectancy, especially after initial surgery. However, no report specifically investigated LGG patients who underwent only resection without oncological therapy. In this study, long-run outcomes were analyzed in LGG patients who never received adjuvant treatment after upfront mapping-based surgical resection. METHODS: Inclusion...

Topics

Join the communities discussing this publication.

• Brain Mapping
• Brain Neoplasms
• Follow-Up Studies
• Glioma
• Isocitrate Dehydrogenase